Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), is one of five approved Breckenridge ANDA products secured from the September 2013 acquisition of certain product assets from Cypress Pharmaceutical.
The company’s Mefenamic Acid Capsules are AB rated to Ponstel, a generic drug marketed by Shionogi Pharma.
Mefenamic acid is indicated for the relief of mild to moderate pain in patients greater than or equal to 14 years of age. The therapy should not exceed one week.
The drug is also indicated to treat primary dysmenorrhea.
Breckenridge is a pharmaceutical marketing, research and development firm that markets a broad range of generic prescription products in many therapeutic categories.
The company markets more than 50 products in a variety of dosage forms and therapeutic categories.